Beck Bode, LLC Pulmonx Corp Transaction History

Beck Bode, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 02, 2022	SELL	$21.13 - $35.65 $2.86 Million - $4.82 Million	-135,217 Closed	0 $0
Q4 2021 Feb 07, 2022	BUY	$29.72 - $45.1 $204,414 - $310,197	6,878 Added 5.36%	135,217 $4.34 Million
Q3 2021 Oct 22, 2021	BUY	$35.98 - $44.48 $428,054 - $529,178	11,897 Added 10.22%	128,339 $4.62 Million
Q2 2021 Jul 29, 2021	BUY	$37.61 - $48.0 $4.38 Million - $5.59 Million	116,442 New	116,442 $5.14 Million

124

31M

300

204K

Ticker LUNG
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 37,268,400
Market Cap $250M
Description
Pulmonx Corporation, a medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. It offers Zephyr Endobronchial Valve, a solution for the treatment of bronchoscopic in adult patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a ...

Get notified when there are updates to the investment portfolio of Beck Bode, LLC, based on Form 13F filings with the SEC.

Stay updated on Beck Bode, LLC with notifications on news.